On Invalid Date, Dermtech (NASDAQ: DMTK) reported Q4 2022 earnings per share (EPS) of -$0.93, up 5.68% year over year. Total Dermtech earnings for the quarter were -$28.22 million. In the same quarter last year, Dermtech's earnings per share (EPS) was -$0.88.
On Invalid Date, Dermtech (NASDAQ: DMTK) reported Q4 2022 revenue of $2.99 million up 5.4% year over year. In the same quarter last year, Dermtech's revenue was $3.17 million.
What was DMTK's revenue growth in the past year?
As of Q1 2023, Dermtech's revenue has grown 22.64% year over year. This is 12.01 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 10.63%. Dermtech's revenue in the past year totalled $14.52 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.